18th Annual Scientific Meeting Posters

Click to view abstract. Posters are listed in alpha order by first author.

Research Experience During COVID-19: Implementing Remote Procedures to Explore Daytime Symptoms and Cognitive Function Among Older Adults with Insomnia (Abstract)

Adornetti

Implementation of quantitative and safety EEG overlaid on a SAD-MAD trial: Challenges and lessons learned (Abstract)

Ballard

Pathways underlying the potential effect of Lactobacillus helveticus in major depression: a randomized, double-blind, placebo-controlled, add-on trial (Abstract)

Bhering Martins

Depression ClinRO inference using momentary multimodal behavioral and physiological digital biomarkers from decentralized data collection (Abstract)

Cicconet

E – Key factors for participant retention: Research sites’ study data and strategies for preventing attrition in depression trials (Abstract)

Cohen

A – Developing a multimodal digital phenotyping paranoia measure: Comprehensive psychometric evaluation (Abstract)

Cohen

Circulating cell-free mtDNA in plasma associated with severity of depressive symptoms in bipolar disorder (Abstract)

Costa

Regional and population differences in schizophrenia clinical trial recruitment rates (Abstract)

Daniel

Characterizing depressive symptom fluctuations using automated speech assessment: a remote feasibility study (Abstract)

DeSouza

Towards proving the validity of computer-supported sleep scoring for pediatric trials (Abstract)

Dorffner

Insulin resistance in depression: A meta-analysis of variation (Abstract)

Fernandes

The Virtual Reality Functional Capacity Assessment Tool (VRFCAT): A normative and standardization study (Abstract)

Horan

Capability of accelerometers in wearable devices for measurement of postural tremor gait and balance and nocturnal scratching (Abstract)

Kelly

Factors impacting collection of continual physiological data in children using wearables deployed in real-world settings (Abstract)

Kim

Application of machine learning algorithms to identify subjects at risk of within PANSS logical errors (Abstract)

Kott

Utilizing patient interviews to inform and optimize the design of a Phase IV clinical trial (Abstract)

MacKenzie

Psychedelic use and placebo response (Abstract)

Morlock

Subjective psychedelic experience and obsessive-compulsive symptom severity (Abstract)

Morlock

Validating the Mobile Toolbox: A remote assessment for measuring cognitive change (Abstract)

Nowinski

Use and validity of patient-reported outcomes in schizophrenia trials (Abstract)

Olt

Identifying EEG-biomarkers of circuit engagement by intramuscular ketamine for the treatment of acute suicidal ideation (Abstract)

Waters

Ecological Momentary Assessment as a potential outcome variable in insomnia research (Abstract)

Wickwire